Research 1st Roundup: July 2026
This quarter’s summaries highlight several studies examining the biological mechanisms of ME/CFS and Long Covid, including the roles of specific autoantibodies and persisting viral components in driving distinct symptoms. Several […]
Webinar Replay: The Discovery of Target Antigens for Dysfunctional T Cells in ME/CFS and Long COVID
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst Award for their study searching for the exact proteins recognized by T-cell receptors from a […]
Solve, Partners Recommend Subgroup Analysis for ME/CFS, POTS, and MCAS in NIH RECOVER TLC Trials
Today, Solve joined #MEAction, Bateman Horne Center, Simmaron Research, Open Medicine Foundation, and other organizations in a sign-on letter urging the National Institutes of Health (NIH) leadership to include subgroup […]
Diffusion MRI Shows How ME/CFS Changes Brain White Matter for Distinct Patient Subgroups
Dr. Zack Shan is director of the neuroimaging program at the University of the Sunshine Coast (Australia), where he specializes in developing new ways to visualize how ME/CFS affects brain […]
New Study Examines ME/CFS Subgroups Based on Cerebrospinal Fluid and Blood-Plasma Proteins
Dr. Akiko Iwasaki, Sterling Professor of Immunology at Yale University and winner of the 2025 Solve Catalyst Award, recently published a study on distinguishing groups of people with ME/CFS based […]
